Displaying 441 - 450 of 496 results
-
Display of combination product medicines in electronic systemsGuidelines for the display of combination product medicines in electronic systems.
-
#O2TheFix toolkitTools developed by Waitematā DHB to encourage the safer prescribing and the best practice use of oxygen therapy, to reduce harm to patients.
-
Safety Signal: Changes to the labelling of Bicillin LA®Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidanceNew dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Opioid implementation packageThis package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Safe use of opioids measurement: frequently asked questionsFrequently asked questions about measurement for the safe use of opioids.
-
Safe use of opioids collaborative information for DHB hospitalsInformation document for DHBs about the breakthrough series collaborative on safe use of opioids in hospitals.
-
Safe Medication Management newsletters - 2010Newsletters from the SMM programme for the year 2010
-
Ninth report of the Perioperative Mortality Review Committee | Te pūrongo tuaiwa o te Komiti Arotake Mate Whai Muri mai i te PokaEquity in major trauma outcomes is the focus of this ninth Perioperative Mortality Review Committee (POMRC) report.